CUA 2023 Abstract Submissions
Abstract Submissions for CUA2023 is now open!
Visit the meeting website to read the guidelines and send in your abstract today.
Deadline: January 13, 2023
Nanaimo Regional General Hospital
The Division of Urology with Island Health has an opening for a full-time Urologist to practice with three other Urologists at the Nanaimo Regional General Hospital.
Standard Synthetic Mid-urethral Sling
As an ongoing commitment to openness and transparency, Health Canada would like to notify you that a summary safety review (SSR) regarding standard synthetic mid-urethral slings and their long-term safety and effectiveness will be published (see attached document). The SSR is intended to provide Canadians with a sufficient understanding of the safety review conducted by Health Canada, specifically what was assessed, what was found and what action was taken.
2022 Update to CRPC guideline is now available!
CUA-CUOG Guideline: Management of castration-resistant prostate cancer (CRPC) is now posted!
Health Canada approves PLUVICTO™
Health Canada approves PLUVICTO™ as first targeted radioligand therapy for progressive PSMA positive metastatic castration-resistant prostate cancer.
APPLY TODAY FOR CPD GRANTS!
Attention Community Urologists: CUA could possibly fund your next scholarly initiative.
Applications are now being accepted to all of CUA's Community Urologist CPD Grants, so apply anytime!
CANADIAN URINARY DIVERSIONS POSITION STATEMENT
CANADIAN URINARY DIVERSIONS POSITION STATEMENT
Collaboration of Canadian Urological Association, Nurses Specialized in Wound, Ostomy and Continence Canada & Urology Nurses of Canada
New PIB posted in Bladder
New patient information brochure, Mid-urethral Sling for the Treatment of Stress Urinary Incontinence in Women has been posted in the Bladder category. CUA members: sign in to view downloadable PDFs.
Copies for print/delivery will be available soon!
- - - -
Une nouvelle brochure d'information pour les patients, La bandelette sous-urétrale pour le traitement de l’incontinence urinaire à l’effort chez la femme, a été publiée dans la catégorie Vessie. Membres de l'AUC : connectez-vous pour visualiser les PDF téléchargeables.
Des copies pour impression/livraison seront bientôt disponibles !
New ADT Guideline just posted!
UPDATE 2022 – Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies
Including summary of changes, summary slides, and executive summary (2021) now available
Listing of CUA Clinical Tools
CUA-developed clinical tools are all available just one click away on:
Integration of TICE and VERITY-BCG(TM)
TO: Physicians Prescribing Treatment for Non-muscle Invasive Bladder Cancer (NMIBC)
- Until 2021, TICE BCG was the only strain available in Canada.
- A second strain of BCG recently received conditional approval by Health Canada in 2021 and is available in the Canadian market: VERITY-BCGTM.
- The past shortage of BCG is therefore resolved.
The Medical Advisory Board of Bladder Cancer Canada, with endorsement by the Canadian Urological Association (2021), has reviewed and support the following suggestions. Click "READ MORE" for full details.
Lupron Depot are Now Back in Stock
AbbVie is pleased to inform you that all formulations of LUPRON DEPOT are now available. More importantly, the inventory shortage which affected the availability of LUPRON DEPOT has now been completely resolved. We do not foresee any future disruptions.
An update on transvaginal mesh for CUA Members
Blayne Welk, Duane Hickling, Greg Bailly, Stephen Steele, Richard Baverstock, Jacques Corcos, Kevin Carlson
2019
The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.
For comments or information, email Corporate.office@cua.org